At 01:13 PM on Tuesday; Nifty Pharma index, the top gainer among sectoral indices, was up 0.2 per cent, as compared to 1.1 per cent decline in the Nifty 50.
Over the past month, Morepen Laboratories has delivered a 34 per cent return, exceeding the Sensex's 2.2 per cent gain
Stocks to Watch today, February 24, 2026: From IDFC First Bank to BPCL, here is a list of shares that will be on investors' radar today
Morepen Labs has secured a ₹825 crore multi-year CDMO mandate from a global pharma major, with supplies set to begin in 4-5 months and execution running through Q1 FY27
Morepen Laboratories share price jumped 15.7 per cent to the day's high of ₹45.40 per share on the National Stock Exchange (NSE)
Morepen Laboratories said supplies under the contract are expected to begin within the next four to five months, while execution is scheduled through the first quarter of the financial year 2026-27
Morepen Laboratories shares jumped 5.7 per cent, after the company arm Morepen Medipath executed a joint venture (JV) agreement with Bimedical FZE, a UAE based entity